相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
Michael Mullen et al.
LANCET (2019)
Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome
Gisela Teixido-Tura et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome
Romy Franken et al.
HEART (2017)
Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial
Alberto Forteza et al.
EUROPEAN HEART JOURNAL (2016)
International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations Results of the MAC (Montalcino Aortic Consortium)
Guillaume Jondeau et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Genotype impacts survival in Marfan syndrome
Romy Franken et al.
EUROPEAN HEART JOURNAL (2016)
International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations Results of the MAC (Montalcino Aortic Consortium)
Guillaume Jondeau et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Arterial tortuosity in genetic arteriopathies
Shaine A. Morris
CURRENT OPINION IN CARDIOLOGY (2015)
Marfan Sartan: a randomized, double-blind, placebo-controlled trial
Olivier Milleron et al.
EUROPEAN HEART JOURNAL (2015)
Increased aortic tortuosity indicates a more severe aortic phenotype in adults with Marfan syndrome
Romy Franken et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Multimodality Imaging of Diseases of the Thoracic Aorta in Adults: From the American Society of Echocardiography and the European Association of Cardiovascular Imaging Endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance
Steven A. Goldstein et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)
Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy
Delphine Detaint et al.
HEART (2014)
Wytyczne ESC dotyczące rozpoznawania i leczenia chorób aorty w 2014 roku
Raimund Erbel et al.
Kardiologia Polska (2014)
Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome
R. V. Lacro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial
Maarten Groenink et al.
EUROPEAN HEART JOURNAL (2013)
Comparison of Clinical Presentations and Outcomes Between Patients With TGFBR2 and FBN1 Mutations in Marfan Syndrome and Related Disorders
David Attias et al.
CIRCULATION (2009)
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
JP Habashi et al.
SCIENCE (2006)
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial
BB Granger et al.
LANCET (2005)
分享论文
